TCL Archive NCI Payline In 1985 Likely To Be 170; $5.9 Million To Be Diverted to AIDS December 7, 1984
TCL Archive Will Latest Report By Rosenberg Stir Up Critics? Some DCT Board Members Defend the Press April 10, 1987
TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
TCL Archive Facilities Survey: $2.5 Billion Will Be Required From 1986-1990, With NCI’s Share At $678 Million April 12, 1985
